Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 21 recruiting now full pipeline

Intracerebral Hemorrhage: full-pipeline trial registry

21 of 32 indexed Intracerebral Hemorrhage trials are currently recruiting.

Corpus placement: #477 of 28,707 conditions by registered trial count.

32 US clinical trials · 21 currently recruiting · #477 of 28,707 conditions by registered trial count

Intracerebral Hemorrhage: 32 US clinical trials tracked, 21 recruiting.

Intracerebral Hemorrhage is the subject of 32 registered US clinical trials on ClinicalTrials.gov, 21 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Joseph Broderick, MD, running 2 of these trials.

Enrollment posture brief

Registry condition intracerebral-hemorrhage

OPEN 21 | RECR 66% | LATE 6 | EARLY 6 | RANK #477 | SPON 2

Nearest open-share peer: Hematopoietic and Lymphoid System Neoplasm (66% recruiting · 32 trials)

Intracerebral Hemorrhage (th…66%Acute Respiratory Distress S43.8%Cardiac Arrest37.5%Astigmatism28.1%Cardiovascular Risk Factor21.9%
Open-enrollment share among volume-matched conditions near Intracerebral Hemorrhage

Intracerebral Hemorrhage lists 21 open slots (66% of 32 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Intracerebral Hemorrhage on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Intracerebral Hemorrhage is recruiting above its size-band peers.

    21 of 32 indexed trials (65.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Intracerebral Hemorrhage trials is spread across many organizations.

    Joseph Broderick, MD accounts for 2 of 32 trials (6.3%). 27 distinct sponsors appear on at least one study for this condition label.

  3. Typical Intracerebral Hemorrhage enrolment sits around 250 participants.

    Median target enrolment is 250 among the 32 trials that report a genuine target (sentinel values excluded). 11 of those (34.4%) plan for fewer than 100 participants.

  4. Intracerebral Hemorrhage splits between interventional and observational designs.

    17 interventional and 15 observational studies make up this index (53.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 23Phase 35Phase 41

Open and recent trials

32 total, page 1 of 1

RECRUITING 8,000 participants

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

Massachusetts General Hospital

NCT04916210

RECRUITING 5,000 participants

Improving Outcomes for Patients With Life-Threatening Neurologic Illness

University of Maryland, Baltimore

NCT04189471

RECRUITING Phase 4 3,500 participants

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Region Skane

NCT06429332

RECRUITING 3,000 participants

Transitions of Care for Stroke Patients

Kiwon Lee MD

NCT06011720

RECRUITING Phase 3 1,456 participants

Statins In Intracerbral Hemorrhage

Beth Israel Deaconess Medical Center

NCT03936361

RECRUITING 1,000 participants

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

Zeenat Qureshi Stroke Institute

NCT06402968

RECRUITING Phase 3 700 participants

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Yale University

NCT03907046

RECRUITING 581 participants

CoMind Early Feasibility Study

CoMind Technologies Limited

NCT06368648

RECRUITING 512 participants

Augmented Renal Clearance in Neurocritical Care

University of Alberta

NCT07410624

RECRUITING Phase 3 350 participants

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

Joseph Broderick, MD

NCT07227246

RECRUITING 250 participants

ROSE-Longitudinal Assessment With Neuroimaging

State University of New York at Buffalo

NCT05089331

RECRUITING Phase 2 200 participants

Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke

Yale University

NCT04760717

RECRUITING 150 participants

Recovery of Consciousness Following Intracerebral Hemorrhage

Columbia University

NCT03990558

RECRUITING Phase 2 120 participants

Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

Johns Hopkins University

NCT05020535

RECRUITING NA 120 participants

Short-term And Longer-term Cognitive Impact Of Neurochecks

University of California, San Diego

NCT06219889

RECRUITING Phase 1 84 participants

Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?

Montefiore Medical Center

NCT05001750

RECRUITING NA 80 participants

Auricular VNS Following Intracerebral Hemorrhage

Washington University School of Medicine

NCT06799390

RECRUITING 50 participants

Hemodynamic ABI Monitor

University of Chicago

NCT06725108

RECRUITING 50 participants

Optical Coherence Tomography Angiography in Neurological Disease

University of Texas Southwestern Medical Center

NCT06797765

RECRUITING 50 participants

Effect of the Stellate Ganglion Block on the Retinal Microcirculation

University of Texas Southwestern Medical Center

NCT06797752

RECRUITING NA 15 participants

Evaluating a Prototype CT Scan for ICH Evacuation

Icahn School of Medicine at Mount Sinai

NCT07455201

ACTIVE NOT RECRUITING Phase 3 860 participants

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial

Joseph Broderick, MD

NCT03496883

ACTIVE NOT RECRUITING NA 728 participants

Implementation of Neuro Lung Protective Ventilation

Colin Grissom

NCT03243539

ACTIVE NOT RECRUITING 72 participants

Florida Cerebrovascular Disease Biorepository and Genomics Center

Mayo Clinic

NCT05491980

COMPLETED 6,000 participants

Addressing Real-world Anticoagulant Management Issues in Stroke

Duke University

NCT02478177

COMPLETED 500 participants

Recovery and Outcomes From Stroke

State University of New York at Buffalo

NCT04007757

COMPLETED Phase 3 499 participants

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Johns Hopkins University

NCT01827046

COMPLETED 163 participants

Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

University of Illinois at Chicago

NCT00490464

COMPLETED Phase 2 92 participants

The Spot Sign for Predicting and Treating ICH Growth Study

University of Cincinnati

NCT00810888

COMPLETED Phase 1 60 participants

Antihypertensive Treatment in Acute Cerebral Hemorrhage

University of Minnesota

NCT00415610

COMPLETED NA 36 participants

Stroke and CPAP Outcome Study 3

University of Washington

NCT06029959

COMPLETED Phase 1 7 participants

Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study

Jesse Corry

NCT03000283

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 3
Phase 3 5
Phase 4 1

Named interventions

Most-linked intervention names on Intracerebral Hemorrhage records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

recombinant activated factor VII Drug
1 trials
rt-PA Drug
1 trials
Nicardipine and Nipride Drug
1 trials
nicardipine Drug
1 trials
Mobile Health intervention Behavioral
1 trials
CPAP technical support intervention Behavioral
1 trials
Motivational Enhancement Therapy (MET) Behavioral
1 trials
Conivaptan Drug
1 trials

US sites by state

Facility locations filed on Intracerebral Hemorrhage trials. A trial with sites in several states counts in each.

California 11 trials
New York 10 trials
Florida 9 trials
Ohio 8 trials
Texas 7 trials
Illinois 6 trials
Arizona 6 trials
North Carolina 5 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Intracerebral Hemorrhage page

32 registered trials, 21 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 21 Intracerebral Hemorrhage trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Joseph Broderick, MD sponsors the most Intracerebral Hemorrhage trials on record, review their full trial history before evaluating a specific study. See Joseph Broderick, MD's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Intracerebral Hemorrhage condition card totals 32 registered trials; most-linked intervention recombinant activated factor VII; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.